US FDA Declines to Approve Revance's Frown-Line Treatment
Revance Therapeutics Inc (RVNC.O) said on Friday the U.S. Food and Drug Administration had declined to approve its ...
Amruta Khandekar Mark Foley Revance Daxibotulinumtoxin Revance Therapeutics Inc Drug Administration Abbvie Inc Abbvn Botox
Source: theepochtimes.com